leisure time -WSS

leisure time

author：comprehensive 2025-09-11 15:31:10 - browse：59

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Ahead of JPM, here's who's profiting most in health care

WSS

PhRMA lawsuit over Medicare drug price negotiation tossed

JPM: CVS says Medicare Advantage patients are impacting profits

'Revelatory' study finds a smoking impact that remains after quitting

Why psychiatrists like me stop taking insurance

Medicare Advantage proposed rates disappoint insurers

AdventHealth escalates lawsuit against insurance vendor Multiplan

explore

leisure time

hotspot

Drug repurposing or repositioning? The language matters

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Videos point to link between seizures and unexplained toddler deaths

United colonoscopy coverage change 'may cost lives,' doctors say

Ahead of JPM, here's who's profiting most in health care

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Chronically ill young patients struggle to find fertility info

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why psychiatrists like me stop taking insurance

entertainment

Biden report: The neurospychology of memory and aging

Robert F. Kennedy is pitching centrism on health, even on abortion

GSK Flovent asthma inhalers replaced by authorized generics

The Readout: Gilead, Bernie Sanders, and other pharma news

U.K. sequencing study surfaces new findings about tumor DNA

Goldman Sachs launches $650M fund for life science investments

entertainment

leisure time

knowledge

hotspot